Human monoclonal antibody to ganglioside GM2 for melanoma treatment - PubMed (original) (raw)

Case Reports

Human monoclonal antibody to ganglioside GM2 for melanoma treatment

R F Irie et al. Lancet. 1989.

No abstract available

PubMed Disclaimer

Similar articles

• Human IgM antibody therapy for HIV-1 infection.
  Okada N, Okada H. Okada N, et al. Microbiol Immunol. 1999;43(8):729-36. doi: 10.1111/j.1348-0421.1999.tb02463.x. Microbiol Immunol. 1999. PMID: 10524789 Review. No abstract available.
• Human monoclonal antibody with dual GM2/GD2 specificity derived from an immunized melanoma patient.
  Yamaguchi H, Furukawa K, Fortunato SR, Livingston PO, Lloyd KO, Oettgen HF, Old LJ. Yamaguchi H, et al. Proc Natl Acad Sci U S A. 1990 May;87(9):3333-7. doi: 10.1073/pnas.87.9.3333. Proc Natl Acad Sci U S A. 1990. PMID: 2159145 Free PMC article.
• Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.
  Livingston PO, Natoli EJ, Calves MJ, Stockert E, Oettgen HF, Old LJ. Livingston PO, et al. Proc Natl Acad Sci U S A. 1987 May;84(9):2911-5. doi: 10.1073/pnas.84.9.2911. Proc Natl Acad Sci U S A. 1987. PMID: 3472242 Free PMC article.
• Characterization of IgG and IgM antibodies induced in melanoma patients by immunization with purified GM2 ganglioside.
  Livingston PO, Ritter G, Srivastava P, Padavan M, Calves MJ, Oettgen HF, Old LJ. Livingston PO, et al. Cancer Res. 1989 Dec 15;49(24 Pt 1):7045-50. Cancer Res. 1989. PMID: 2582446

Cited by

• Chemical Synthesis of GM2 Glycans, Bioconjugation with Bacteriophage Qβ, and the Induction of Anticancer Antibodies.
  Yin Z, Dulaney S, McKay CS, Baniel C, Kaczanowska K, Ramadan S, Finn MG, Huang X. Yin Z, et al. Chembiochem. 2016 Jan;17(2):174-80. doi: 10.1002/cbic.201500499. Epub 2015 Dec 4. Chembiochem. 2016. PMID: 26538065 Free PMC article.
• The novel panel assay to define tumor-associated antigen-binding antibodies in patients with metastatic melanomas may have diagnostic value.
  Kotlan B, Liszkay G, Blank M, Csuka O, Balatoni T, Toth L, Eles K, Horvath S, Naszados G, Olasz J, Banky B, Toth J, Godeny M, Marincola FM, Kasler M, Shoenfeld Y. Kotlan B, et al. Immunol Res. 2015 Feb;61(1-2):11-23. doi: 10.1007/s12026-014-8600-6. Immunol Res. 2015. PMID: 25480739
• Accelerated tumor growth mediated by sublytic levels of antibody-induced complement activation is associated with activation of the PI3K/AKT survival pathway.
  Wu X, Ragupathi G, Panageas K, Hong F, Livingston PO. Wu X, et al. Clin Cancer Res. 2013 Sep 1;19(17):4728-39. doi: 10.1158/1078-0432.CCR-13-0088. Epub 2013 Jul 5. Clin Cancer Res. 2013. PMID: 23833306 Free PMC article.
• Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patients.
  Koyanagi K, Kuo C, Nakagawa T, Mori T, Ueno H, Lorico AR Jr, Wang HJ, Hseuh E, O'Day SJ, Hoon DS. Koyanagi K, et al. Clin Chem. 2005 Jun;51(6):981-8. doi: 10.1373/clinchem.2004.045096. Epub 2005 Apr 7. Clin Chem. 2005. PMID: 15817820 Free PMC article.
• Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions.
  Gerlini G, Tun-Kyi A, Dudli C, Burg G, Pimpinelli N, Nestle FO. Gerlini G, et al. Am J Pathol. 2004 Dec;165(6):1853-63. doi: 10.1016/S0002-9440(10)63238-5. Am J Pathol. 2004. PMID: 15579430 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations

• Medical

  • MedlinePlus Health Information